Histopathological imaging features- versus molecular measurements-based cancer prognosis modeling

• Published in: Scientific reports Vol. 10; no. 1; p. 15030
• Main Authors: Zhang, Sanguo, Fan, Yu, Zhong, Tingyan, Ma, Shuangge
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 14-09-2020; Nature Publishing Group
• Subjects: 631/114; 631/67; Aged; Biomarkers, Tumor - genetics; Biomarkers, Tumor - metabolism; Biomarkers, Tumor - standards; Biopsy; Computational Biology - methods; Computational Biology - standards; Cytodiagnosis - methods; Cytodiagnosis - standards; Diagnosis, Computer-Assisted - methods; Diagnosis, Computer-Assisted - standards; Female; Gene Expression Regulation, Neoplastic; Humanities and Social Sciences; Humans; Lung cancer; Lung Neoplasms - genetics; Lung Neoplasms - metabolism; Lung Neoplasms - pathology; Male; Medical prognosis; Middle Aged; multidisciplinary; Prognosis; Science; Science (multidisciplinary); Survival
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-020-72201-5

For lung and many other cancers, prognosis is essentially important, and extensive modeling has been carried out. Cancer is a genetic disease. In the past 2 decades, diverse molecular data (such as gene expressions and DNA mutations) have been analyzed in prognosis modeling. More recently, histopathological imaging data, which is a “byproduct” of biopsy, has been suggested as informative for prognosis. In this article, with the TCGA LUAD and LUSC data, we examine and directly compare modeling lung cancer overall survival using gene expressions versus histopathological imaging features. High-dimensional penalization methods are adopted for estimation and variable selection. Our findings include that gene expressions have slightly better prognostic performance, and that most of the gene expressions are weakly correlated imaging features. This study may provide additional insight into utilizing the two types of important data in cancer prognosis modeling and into lung cancer overall survival.